Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

Sustained effectiveness, safety and therapeutic drug monitoring of tioguanine in a cohort of 274 IBD patients intolerant for conventional therapies.

Simsek M, Deben DS, Horjus CS, Bénard MV, Lissenberg-Witte BI, Buiter HJC, van Luin M, Seinen ML, Mulder CJJ, Wong DR, de Boer NKH, van Bodegraven AA.

Aliment Pharmacol Ther. 2019 Jul;50(1):54-65. doi: 10.1111/apt.15280. Epub 2019 May 16.

PMID:
31094013
2.

Monitoring of tobramycin serum concentrations in selected critically ill patients receiving selective decontamination of the digestive tract: a retrospective evaluation.

Möhlmann JE, van Luin M, Mascini EM, van Leeuwen HJ, de Maat MR.

Eur J Clin Pharmacol. 2019 Jun;75(6):831-836. doi: 10.1007/s00228-019-02644-x. Epub 2019 Feb 18.

PMID:
30778624
3.

A design for external quality assessment for the analysis of thiopurine drugs: pitfalls and opportunities.

Robijns K, van Luin M, Jansen RTP, Neef C, Touw DJ.

Clin Chem Lab Med. 2018 Sep 25;56(10):1715-1721. doi: 10.1515/cclm-2018-0116. No abstract available.

PMID:
30110249
4.

[Metformin-associated lactic acidosis: an insufficiently recognised problem].

Manders M, van Luin M, Kramers C, Bosch FH.

Ned Tijdschr Geneeskd. 2017;161:D1823. Review. Dutch.

PMID:
29125081
5.

Post-mortem findings in 22 fatal Taxus baccata intoxications and a possible solution to its detection.

Reijnen G, Bethlehem C, van Remmen JMBL, Smit HJM, van Luin M, Reijnders UJL.

J Forensic Leg Med. 2017 Nov;52:56-61. doi: 10.1016/j.jflm.2017.08.016. Epub 2017 Aug 25. Review.

PMID:
28865388
6.

Valproate Intoxication in a Patient With Blood Valproate Levels Within Therapeutic Range.

Smits JEMP, Wallenburg E, van Spanje A, van Luin M, Marijnissen RM.

J Clin Psychiatry. 2017 Apr;78(4):e413-e414. doi: 10.4088/JCP.15cr10147. No abstract available.

7.

Monitoring Protein-Unbound Valproic Acid Serum Concentrations in Clinical Practice.

Wallenburg E, Klok B, de Jong K, de Maat M, van Erp N, Stalpers-Konijnenburg S, Essink G, van Luin M.

Ther Drug Monit. 2017 Jun;39(3):269-272. doi: 10.1097/FTD.0000000000000405.

PMID:
28437285
8.

Zidovudine continuous infusion in an HIV-infected pregnant woman with a phobia of swallowing pills.

van Luin M, Ter Beest G, Wijnberger LE, Swanink CM, Burger DM, Gisolf JH.

Antivir Ther. 2017;22(8):727-729. doi: 10.3851/IMP3164.

PMID:
28367828
9.

Measuring Plasma Concentrations of Ribavirin: First Report From a Quality Control Program.

Smolders EJ, Kan R, de Kanter CT, van Luin M, Aarnoutse RE, Touw DJ, Burger DM.

Ther Drug Monit. 2016 Oct;38(5):646-7. doi: 10.1097/FTD.0000000000000319. No abstract available.

PMID:
27355493
10.

Interference of therapeutic monoclonal immunoglobulins in the investigation of M-proteins.

Ruinemans-Koerts J, Verkroost C, Schmidt-Hieltjes Y, Wiegers C, Curvers J, Thelen M, van Luin M.

Clin Chem Lab Med. 2014 Nov;52(11):e235-7. doi: 10.1515/cclm-2013-0898. No abstract available.

PMID:
24810561
11.

The validity of the modification of diet in renal disease formula in HIV-infected patients: a systematic review.

Eppenga WL, van Luin M, Richter C, Derijks HJ, De Smet PA, Wensing M.

J Nephrol. 2014 Feb;27(1):11-8. doi: 10.1007/s40620-013-0012-5. Epub 2013 Dec 20. Review.

PMID:
24519861
12.

Pharmacokinetics of the combination raltegravir/atazanavir in HIV-1-infected patients.

Jansen A, Colbers EP, van der Ven AJ, Richter C, Rockstroh JK, Wasmuth JC, van Luin M, Burger DM.

HIV Med. 2013 Aug;14(7):449-52. doi: 10.1111/hiv.12029. Epub 2013 Mar 18.

13.

Adherence to HIV therapeutic drug monitoring guidelines in The Netherlands.

van Luin M, Wit FW, Smit C, Rigter IM, Franssen EJ, Richter C, Kroon F, de Wolf F, Burger DM.

Ther Drug Monit. 2011 Feb;33(1):32-9. doi: 10.1097/FTD.0b013e318205b81d.

PMID:
21192311
14.

Effect of posaconazole on the pharmacokinetics of fosamprenavir and vice versa in healthy volunteers.

Brüggemann RJ, van Luin M, Colbers EP, van den Dungen MW, Pharo C, Schouwenberg BJ, Burger DM.

J Antimicrob Chemother. 2010 Oct;65(10):2188-94. doi: 10.1093/jac/dkq280. Epub 2010 Jul 28.

PMID:
20667889
15.

No changes in efavirenz plasma concentrations in HIV-infected patients who switch from Stocrin to Atripla.

Burger D, van Luin M, Bosch M, van der Ven A, Brouwer AM, Keuter M, Dofferhoff T, Koopmans PP.

J Acquir Immune Defic Syndr. 2010 Aug;54(5):e12-3. doi: 10.1097/QAI.0b013e3181ed1896. No abstract available.

PMID:
20647821
16.

Drug-drug interactions between raltegravir and pravastatin in healthy volunteers.

van Luin M, Colbers A, van Ewijk-Beneken Kolmer EW, Verweij-van Wissen CP, Schouwenberg B, Hoitsma A, da Silva HG, Burger DM.

J Acquir Immune Defic Syndr. 2010 Sep;55(1):82-6. doi: 10.1097/QAI.0b013e3181d9a354.

PMID:
20395869
17.

Lower atovaquone/proguanil concentrations in patients taking efavirenz, lopinavir/ritonavir or atazanavir/ritonavir.

van Luin M, Van der Ende ME, Richter C, Visser M, Faraj D, Van der Ven A, Gelinck L, Kroon F, Wit FW, Van Schaik RH, Kuks PF, Burger DM.

AIDS. 2010 May 15;24(8):1223-6. doi: 10.1097/QAD.0b013e3283389129.

PMID:
20299957
18.

The effect of raltegravir on the glucuronidation of lamotrigine.

van Luin M, Colbers A, Verwey-van Wissen CP, van Ewijk-Beneken-Kolmer EW, van der Kolk M, Hoitsma A, da Silva HG, Burger DM.

J Clin Pharmacol. 2009 Oct;49(10):1220-7. doi: 10.1177/0091270009345689. Epub 2009 Aug 28.

PMID:
19717722
19.

Efavirenz dose reduction is safe in patients with high plasma concentrations and may prevent efavirenz discontinuations.

van Luin M, Gras L, Richter C, van der Ende ME, Prins JM, de Wolf F, Burger DM, Wit FW.

J Acquir Immune Defic Syndr. 2009 Oct 1;52(2):240-5. doi: 10.1097/QAI.0b013e3181b061e6.

PMID:
19593159
20.

Use of therapeutic drug monitoring in HIV disease.

van Luin M, Kuks PF, Burger DM.

Curr Opin HIV AIDS. 2008 May;3(3):266-71. doi: 10.1097/COH.0b013e3282f82c1b.

PMID:
19372977
21.

Absence of a relation between efavirenz plasma concentrations and toxicity-driven efavirenz discontinuations in the EuroSIDA study.

van Luin M, Bannister WP, Mocroft A, Reiss P, Di Perri G, Peytavin G, Molto J, Karlson A, Castagna A, Beniowski M, Lundgren JD, Burger DM; EuroSIDA Study Group.

Antivir Ther. 2009;14(1):75-83.

PMID:
19320239
22.

Efavirenz dose reduction to 200 mg once daily in a patient treated with rifampicin.

van Luin M, Brouwer AM, van der Ven A, de Lange W, van Schaik RH, Burger DM.

AIDS. 2009 Mar 27;23(6):742-4. doi: 10.1097/QAD.0b013e32832914a3. No abstract available.

PMID:
19279450
23.

[Acute caffeine intoxication after intake of 'herbal energy capsules'].

Kromhout HE, Landstra AM, van Luin M, van Setten PA.

Ned Tijdschr Geneeskd. 2008 Jul 12;152(28):1583-6. Dutch.

PMID:
18712229
24.

Reality of severe metformin-induced lactic acidosis in the absence of chronic renal impairment.

Bruijstens LA, van Luin M, Buscher-Jungerhans PM, Bosch FH.

Neth J Med. 2008 May;66(5):185-90. Review.

Supplemental Content

Loading ...
Support Center